Premier Health of America Announces Grant of Management Cease Trade Order

Premier Health of America Announces Grant of Management Cease Trade Order

Premier Health of America INC. (TSX-V: PHA) ("Premier Health", or the "Company") announces that, further to its press release dated June 2, 2026, the Autorité des marchés financiers, as the Company's principal regulator, has granted a management cease trade order (the "MCTO") under National Policy 12-203 Management Cease Trade Orders.

As previously announced, the Company's unaudited interim financial statements and the related management's discussion and analysis for the quarter ended March 31, 2026 (the "Required Filings") were not filed by June 1, 2026, being the filing deadline prescribed under applicable Canadian securities law requirements.

The MCTO prohibits the Company's Interim Chief Executive Officer, the Interim Chief Financial Officer and the members of the Board of Directors from trading securities of the Company for so long as the Required Filings remain outstanding. The issuance of the MCTO does not affect the ability of persons other than insiders of the Company to trade in the Company's securities.

The Company currently expects to file the Required Filings on or before June 30, 2026, and will issue a press release announcing completion of such filings once completed. Until the Company files the Required Filings, it will comply with the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders. These guidelines require the Company to issue bi-weekly default status reports by way of press release during the period of the MCTO.

Following the June 2, 2026, press release, the Company is currently in default under its credit facilities. No new forbearance agreement is currently being negotiated and the Company continues to assess its available options.

About Premier Health

Premier Health is a leading Canadian Healthtech company that provides a comprehensive range of outsourced services solutions for healthcare needs to governments, companies, and individuals. Premier Health uses its proprietary LiPHe® platform to lead the digital transformation of the healthcare services sector, providing patients with faster, more affordable, and more accessible care.

For Further Information Please Contact:

Mr. Guy D'Aoust
Interim Chief Executive Officer
Premier Health of America Inc.
gdaoust@premierhealth.ca / 1 800 231 9916
Mr. Frédéric St-Cyr
Interim Chief Financial Officer
Premier Health of America Inc.
fstcyr@premierhealth.ca / 1 800 231 9916



Primary Logo

News Provided by GlobeNewswire via QuoteMedia

PHA:CC
The Conversation (0)
Premier Health of America

Premier Health of America

Modernizing Healthcare Staffing with Automated, On-Demand Services

Modernizing Healthcare Staffing with Automated, On-Demand Services Keep Reading...
Seegnal (TSXV:SEGN)

Seegnal Presents Real-World Evidence on Reducing Fall Risk in Geriatric Patients at Caltcm Summit

Seegnal Inc. (TSXV: SEGN) ("Seegnal" or the "Corporation"), a global leader in AI-enhanced prescription intelligence, today announced real-world clinical results demonstrating how medication governance may reduce fall-risk drivers in older adults -- a significant clinical and financial challenge... Keep Reading...
Cardiologist wearing virtual reality glasses.

Top 3 Medical Device ETFs for Investors in 2026

Exchange-traded funds (ETFs) are a popular investment strategy, and generally contain a variety of publicly traded companies under one stock symbol, often with a focus on a specific sector.Depending on the ETF, investors may be able to track up-and-coming companies, get exposure to top firms or... Keep Reading...
Stethoscope connected to a phone with medical data overlay.

Top 3 Small-cap Medical Device Stocks (Updated January 2026)

The growing prevalence of chronic diseases like cancer and diabetes is driving increasing innovation in medical device technology. In 2024 alone, 30 new devices were approved by the US Food and Drug Administration (FDA).Wearable medical devices and the use of artificial intelligence in medical... Keep Reading...
Scientists working in a modern medical research laboratory.

Pathways to Commercialising Biotech Innovations

In the medical technology industry, innovation is only the first step. While key to long-term success, innovation is only as good as a company’s commercialisation strategy. Once a technology has been developed and proven, the organisation must then embark on a process to commercialise it for... Keep Reading...
Medical devices on a desk.

How to Invest in Medical Device Stocks and ETFs

The medical device market offers investors unique exposure to the overall life science space, especially in an era of fast-growing tech advancements in healthcare.This industry covers a wide range of health and medical instruments and equipment used in the treatment, mitigation, diagnosis and... Keep Reading...
illustration of brain and cell phone.

BlinkLab Completes First Patient Test for US Autism Diagnostic Study

Digital healthcare company BlinkLab (ASX:BB1) has tested the first patient in its US autism diagnostic study, which is geared at validating the company's Dx1 test as a diagnostic aid for clinicians. BlinkLab states in its Wednesday (March 12) release that the study is the largest digital... Keep Reading...

Interactive Chart

Latest Press Releases

Related News